Healthcare
Inveready leads €600,000 round for Ojer Pharma
Funding will help bring new dermatology products to market
N+1 et al. sell Xanit Group to Vithas
N+1 backed the business in 2007
VC-backed arGEN-X raises €40m in IPO
Company will list on Euronext Brussels on 10 July
Seventure and LSP invest €4.4m in Mint
Funding round saw participation from existing backers
Equistone backs $100m Concept formation
Investment made from GP's тЌ1.5bn Fund IV
Ardian underwrites €255m facility for Ceva buyout
GP had already backed Ceva in 2007 and 2012
Calculus et al. invest £7.25m in Premaitha
Premaitha has market cap of ТЃ19m
to-BBB raises €10m series-C
Antea now holds a stake of around 10% in to-BBB
VC-backed Affimed to float
Plans to raise up to $75m in IPO, according to SEC filing
VC backers take part in €50m Innate Pharma capital increase
Investors include Wellington Partners, OrbiMed and BPI France
CVC to take over 3i's Vedici
Firm enters exclusive negotiations for private hospital group
VC-backed Pixium floats with €100m market cap
Company sold 4.2 million shares at 828 euro cents apiece
Auriga et al. invest €5m in Fab'entech
Company will use funds to expand internationally
Nordic Nanovector closes pre-IPO private placement
Oversubscribed placement saw price pushed up to NOK 250m from NOK 150m
VC-backed Abzena plans flotation
No details of flotation have been released
IK divests GHD to Nordic Capital
Nordic Capital Fund VIII used to make transaction
CRB Inverbio takes 50% stake in Mecwins
Madrid-based life sciences specialist Cross Road Biotech Inversiones Biotecnológicas (CRB) has acquired a 50% stake in biotech start-up Mecwins for around €4m.
CVC to buy Doughty's Quirón
Consolidation begins in Spanish hospital market
Inveni, Omega invest €2.5m in BioSilta
Fresh capital to be used for further commercial development
Nixen exits Ceva Santé Animale
Company management and employees to remain majority shareholder
VC-backed arGEN-X announces IPO plans
Plans to offer new shares to raise fresh funding for company
PAI acquires DomusVi
Deal was sourced through an auction process
Archimed reaches €100m first close for maiden healthcare fund
3i spinout reaches milestone after three months on the road
Sovereign exits Tracscare to G Square
Sovereign first invested in the company in 2004